Hutchmed China (0013.HK) traded up 0.98 % during a 24 hours period ending at 05:34 PM Central Europe on Monday 26th. One Hutchmed China stock can currently be bought for about HKD 22.56 on popular exchanges. Current supply of Hutchmed China stocks is 869.1 mn. Hutchmed China has a current market capitalization of HKD 19.6 bn and approximately HKD 56.6 mn worth of Hutchmed China was traded on exchanges in the last 24 hours. Since last month end, Hutchmed China has traded 2.64 % up. Simple moving average of last 200 days is at HKD 20.85. The highest price of past 52 weeks was recorded at HKD 25.58 on 01/16/2026. 52 weeks low was at HKD 15.57 on 06/22/2026.

Summary of the latest news for Hutchmed China

AstraZeneca’s experimental antibody drug conjugate, sonesitatug vedotin, has demonstrated a substantial survival benefit in a late‑stage gastric‑cancer study. In patients whose disease progressed after at least one line of therapy, the agent extended median overall survival by approximately five months compared with standard chemotherapy, while maintaining a manageable safety profile. The benefit was most pronounced in patients receiving the drug after two prior therapies. The data, presented at the European Society for Medical Oncology Congress, support the potential of sonesitatug vedotin to replace conventional chemotherapy in this setting and suggest a significant commercial opportunity for the company.

Here is how related stocks have performed in the past 24 hours:

  • Guoco (0053.HK) traded down -0.15 % and now trades at HKD 68.75. Current market capitalisation for Guoco is HKD 22.6 bn. Current price/earnings ratio for Guoco is 6.96.

  • Ts Lines (2510.HK) traded down -1.28 % and now trades at HKD 12.69. Current market capitalisation for Ts Lines is HKD 20.5 bn.

  • Insilico Medicine Cayman Top (3696.HK) traded up 1.22 % and now trades at HKD 36.5. Current market capitalisation for Insilico Medicine Cayman Top is HKD 21 bn.

  • Yue Yuen Industrial (0551.HK) traded up 1.34 % and now trades at HKD 14.3. Current market capitalisation for Yue Yuen Industrial is HKD 23.1 bn. Current price/earnings ratio for Yue Yuen Industrial is 10.35.

  • China Ruyi (0136.HK) traded up 0.74 % and now trades at HKD 1.36. Current market capitalisation for China Ruyi is HKD 22.6 bn. China Ruyi has a current price to earnings ratio of 15.6.

About Hutchmed China

HUTCHMED (China) Limited is a health care sector company based in Hong Kong that specializes in developing, manufacturing, and selling pharmaceutical products. The company offers drugs for oncology and autoimmune diseases treatment and markets its products globally. You can find more information about their offerings and initiatives on their website, www.hutch-med.com , and they are listed on the Hong Kong Stock Exchange.